Filed under: Arizona, Arizona Biotech, Arizona Technology, ASU, City of Tempe, City of Tempe News, Community, Tempe, Tempe Arizona, US - AZ (Phoenix) | Tags: Arizona, az, News, Phoenix, Phoenix Arizona, scientists, Tempe
TEMPE, Ariz. — The unknown human health and environmental impacts of nanotechnology are a bigger worry for scientists than for the public, according to a new report published on line (November 25, 2007) in the journal Nature Nanotechnology.
The report was based on a national telephone survey of American households and a sampling of 363 leading U.S. nanotechnology scientists and engineers. It reveals that those with the most insight into a technology with enormous potential — and that is already emerging in hundreds of products — are unsure what health and environmental problems might be posed by the technology.
Two Arizona State University researchers – Elizabeth Corley, an assistant professor in the School of Public Affairs, and David Guston, director of the Center for Nanotechnology in Society and a professor of political science, are co-authors of the paper.
“It’s unusual for experts to see a greater risk in new technologies than for the public at large,” Guston said. “But these findings do not mean that scientists are saying that there is a problem.”
“Scientists are saying, ‘we don’t know,” explained the study’s lead author Dietram Scheufele, a University of Wisconsin-Madison professor of life sciences communication and journalism. “The research hasn’t been done.’”
The new findings are in stark contrast to controversies sparked by the advent of major technologies of the past, such as nuclear power and genetically modified foods, which scientists perceived as having lower risks than did the public.
Nanotechnology is based on science’s newfound ability to manipulate matter at the smallest scale, on the order of molecules and atoms. The field has enormous potential to develop applications ranging from new antimicrobial materials and tiny probes to sample individual cells in human patients, to vastly more powerful computers and lasers. Already, products with nanotechnology built in include such things as golf clubs, tennis rackets and antimicrobial food storage containers.
At the root of the information disconnect, said Elizabeth Corley, who conducted the survey with Scheufele, is that nanotechnology is only now starting to emerge on the nation’s policy agenda. Amplifying the problem is that the news media have not paid much attention to nanotechnology and its implications.
“In the long run, this information disconnect could undermine public support for federal funding in certain areas of nanotechnology research, particularly in those areas that the public views as having lower levels of risk,” Corley said.
While scientists were generally optimistic about the potential benefits of nanotechnology, they expressed significantly more concern about pollution and new health problems related to the technology. Potential health problems were in fact the highest rated concern among scientists, Guston said.
Twenty percent of the scientists responding to the survey indicated a concern that new forms of nanotechnology pollution may emerge, while only 15 percent of the public thought that might be a problem. More than 30 percent of scientists expressed concern that human health may be at risk from the technology, while just 20 percent of the public held such fears.
Of more concern to the American public, according to the report, are a potential loss of privacy from tiny new surveillance devices and the loss of more U.S jobs. Those fears were less of a concern for scientists.
While scientists wonder about the health and environmental implications of the new technology, their ability to spark public conversation seems to be limited, Corley and Guston said.
That’s because “scientists tend to treat communication as an afterthought,” Wisconsin’s Scheufele added. “They’re often not working with social scientists, industry or interest groups to build a channel to the public.”
The good news for scientist is that of all sources of nanotechnology information, they are the most trusted by the public.
“The public wants to know more about nanotechnology,” Guston added. “That’s why the Center for Nanotechnology in Society at ASU is conducting additional polls of the public and of scientists, and is organizing a National Citizens’ Technology Forum to elicit informed public perspectives on nanotechnology.”
“The climate for having that discourse is perfect,” Scheufele added. “There is definitely a huge opportunity for scientists to communicate with a public who trusts them.”
In addition to ASU’s Corley and Guston and Wisconsin’s Scheufele, other authors of the Nature Nanotechnology report include Sharon Dunwoody, Tsung-Jen Shih and Elliott Hillback of University of Wisconsin-Madison. The study was funded by the National Science Foundation as part of the Center for Nanotechnology in Society at Arizona State University and the UW-Madison Graduate School.
Filed under: Arizona Biotech, Arizona State University, Arizona Technology, ASU, City of Tempe, City of Tempe News, Education, Tempe, Tempe Arizona | Tags: Donations
TEMPE, Ariz. – Arizona State University’s research expenditures grew to $218.5 million in the fiscal year that ended June 30. This represents a growth of $15 million or 7.4 percent over last year’s total of $203.5 million.
“We experienced decent growth in our research expenditures this year, considering that there was a change in leadership in Congress that resulted in some delays in finalizing the Federal budget,” said R.F. “Rick” Shangraw, ASU’s vice president for research and economic affairs. “Right now, our proposal activity is up so I am optimistic about continued growth in our research portfolio.”
Shangraw added that at these levels of research expenditures, ASU ranks in the top tier of universities without a medical school and without an agricultural school.
The $218.5 million total research dollars for FY07 comes from a variety of sources. ASU spent $173.3 million in funds received from the federal government and industry, $39.1 million in state funds (including Technology & Research Initiative Funds from state sales tax revenue), $4.3 million in funds received by the ASU Foundation specifically for research projects and $1.8 million from local governments.
There was a wide variety of projects that brought in major funds in FY07, said Stephen Goodnick, ASU associate vice president for research. Those projects included the Flexible Display Initiative Center, which was funded at more than $9 million by the U.S. Army; the Lunar Reconnaissance Orbiter Camera project got $3.85 million from NASA; a Department of Education grant of $2.35 million went to a program at ASU’s Speech and Hearing Science Department to maximize learning opportunities for young children with disabilities, and $2.35 million from the National Science Foundation (NSF) was provided to the Center for Research on Education in Science, Mathematics, Engineering and Technology for a project on “opening routes to math and science success for all students.”
The National Institutes of Health awarded $1.44 million for a project to explore plant-made microbiocides and mucosal vaccines; ASU’s Decision Center for a Desert City received $1.4 million from the NSF; and ASU’s Nanotechnology in Society Center received $1.4 million from NSF.
Fiscal year 2006 was the first time research expenditures at ASU topped the $200 million level, and it marked a doubling of research expenditures in a period of six years. This is a remarkable growth rate for a relatively young major research university, Shangraw said.
He adds that ASU is poised to earn more in research as it continues to bring on line new world class research facilities and ramps up its science expertise. Shangraw sees a maturing of ASU research efforts, which should result in securing larger grants for the university in the future.
“We have reached a point where a number of investigators are interested in and able to compete for much larger research projects,” he explained. “Our ability to match up against the more mature and better funded research institutions is a sign that we are moving into an elite tier of U.S. research universities. This is an exciting time for ASU research.”
Filed under: Arizona, Arizona Biotech, Arizona Jobs, Arizona State University, Arizona Technology, ASU, Awards, Biotech, City of Tempe, Medical, Phoenix Arizona, Science, State of Arizona, Tempe, Tempe Arizona, US - AZ (Phoenix) | Tags: Award, Biomedical
Bee researcher at Arizona State University is one of 20 new Pew Scholars in the biomedical sciences
TEMPE, Ariz.– It’s hard to imagine, for most of us, that the bees we see buzzing between strands of orange flowers of the desert mallow could potentially usher in a medical breakthrough. However, in the right hands, these insects best known for their banded coloration, social life and skills with pollination could some day be the key to advancements in biomedical neuroscience of aging – if Gro Amdam has her way, with support from The Pew Charitable Trusts.
Amdam, an assistant professor in Arizona State University’s School of Life Sciences who heads social insect studies in laboratories at both ASU and the Norwegian University of Life Sciences’ Department of Animal and Aquacultural Sciences, is one of only 20 researchers chosen this year to enter the Trusts’ exclusive rolls as a Pew Scholar in the biomedical sciences. About 150 eligible colleges across the nation were invited to submit a candidate for the award this year. Remarkably, it was the first year that Arizona State University was invited to participate and Amdam was the sole candidate put forward by ASU President Michael M. Crow.
“The focus of this award – biomedical sciences – is an evolving area of emphasis for ASU,” says Crow. “The fact that the award is going to a researcher using the honeybee as a biomedical model exemplifies the spirit of ASU unconstrained by disciplinary boundaries.”
Robert Page, founding director of ASU’s School of Life Sciences and Amdam’s oft-time collaborator in the College of Liberal Arts and Sciences, says he never had any doubt that the Pew Trusts would select Amdam, and that the award has special significance on several fronts: “This the first year that ASU was invited to nominate, so it marks our initiation as an institution into this select ’club.’ The fact that our faculty member was chosen also shows that ASU belongs in the club. Then, when you consider that this award is in the area of biomedical science and will support research using honeybees … it shows just how much the world of biology is changing and that comparative biology will be central even to the biomedical sciences.”
The Pew Charitable Trusts is composed of seven separate trusts established between 1948 and 1979 by the heirs of Joseph N. Pew, founder of the Sun Oil Company, and is driven by the power of knowledge to solve today’s most challenging problems. Pew applies a rigorous, analytical approach to improve public policy, inform the public and stimulate civic life. It partners with a diverse range of donors, public and private organizations and concerned citizens who share its commitment to fact-based solutions and goal-driven investments to improve society.
“The Pew Scholars are among America’s finest biomedical research entrepreneurs. They seek out and mine unexpected leads in a quest for knowledge that may one day lead to new medical treatments and save lives,” says Rebecca W. Rimel, president and chief executive office of The Pew Charitable Trusts.
As a Pew Scholar, Amdam will receive a $240,000 award over four years to help support her research.
Among past Pew Scholars are Nobel Prize winners, such as Craig Mello from the University of Massachusetts, who shared the 2006 Nobel Prize for Physiology or Medicine with Stanford’s Andrew Fire for their development of the RNA interference (RNAi) technique. Amdam’s research will make use of RNAi to study genes implicated in plasticity of honeybee neuronal aging.
Of the award, Amdam says, “In the scholarly system of Norway, where I come from, such recognitions are very rare, nearly unheard of. This is a great honor for me.” She also notes, “The award gives me a unique opportunity to take my research at ASU into the field of neuroscience, and neurogerontology in particular.”
According to Amdam, her Pew project will join two lines of study that have never been coupled: the emerging field of honeybee comparative neurogerontology – in which Amdam has published the first work on plasticity of neuronal oxidative damage – and honeybee behavioral physiology, where cumulative data show that age-related cell damage can be reversed. Amdam has authored or coauthored publications in Nature, Public Library of Science Biology, Advances in Cancer Research, Proceedings of the National Academy of Sciences, Experimental Gerontology and Behavioral Brain Research in the past year, laying the foundation for this work. Her group has documented that social reversal, which triggers old bees (that usually forage outside of the hive) to revert to tasks normally performed by younger bees (that nurse larvae within the hive), is associated with reversal of several physiological markers of senescence. Her findings, and supporting findings from other groups, Amdam says, indicate that “behavioral reversal triggers a systemic response, one which translates into a unique cascade of cell repair in bees.” Preliminary data collected in her laboratory suggest that this cascade can include the central nervous system.
“If social reversal causes arrest or partial clearance of neuronal oxidative damage, my project funded by The Pew Charitable Trusts will establish the first model for neuronal oxidative remission,” Amdam notes.
Oxidative brain damage is a fundamental pathology in normal human aging and in Alzheimer’s and Parkinson’s disease, and development of novel treatments has high priority in biomedical research, says Amdam. Although she describes this line of discovery as risky, “its prospective contribution is of considerable relevance for human health.”
Filed under: Arizona, Arizona Biotech, Arizona Technology, Biotech, Business, City of Phoenix News, News | Tags: Arizona Public Service, Recycling
Arizona Public Service and GreenFuel
Technologies Corp. Successfully
Recycle Power Plant Flue Gases into
Transportation-Grade Biodiesel
and Ethanol
Algae Bioreactor System Connected Directly to Smokestack of APS’ Redhawk 1,040 Megawatt Power Plant Recycles Greenhouse Gases into Renewable Biofuels
Arizona Public Service Company (APS) and GreenFuel Technologies Corporation have announced that they have successfully recycled the carbon dioxide (CO2) from the stack gases of a power plant into transportation grade biofuels. The announcement was made at the Platts Global Energy Awards ceremonies today in New York. Using GreenFuel’s Emissions-to-Biofuels™ algae bioreactor system connected to APS’ 1,040 megawatt Redhawk power plant in Arlington, Arizonan, GreenFuel was able to create a carbon-rich algal biomass with sufficient quality and concentration of oils and starch content to be converted into transportation-grade biodiesel and ethanol.
“This is the first time ever that algae biomass created on-site by direct connection to a commercial power plant has been successfully converted to both these biofuels,” said Isaac Berzin, GreenFuel’s founder and Chief Technology Officer. “The conversion and certification of the fuels were conducted by respected, independent laboratories.”
GreenFuel’s Emissions-to-Biofuels™ technology uses safe, naturally occurring algae to recycle carbon dioxide from the stack gases of power plants and other commercial sources of continuous CO2 emissions. At the Redhawk Power Plant, specially designed pipes captured and transported the CO2 emissions coming out of the stack. The gas was then transferred to specialized containers holding hungry algae. Algae are unicellular plants and, like all plants, they divide and grow using the process known as photosynthesis. In the presence of sunlight, algae consume CO2.
“We estimate that this process can absorb as much as 80 percent of CO2 emissions during the daytime at a natural gas fired power plant,” said GreenFuel CEO Cary Bullock. “Unlike typical agricultural biofuel feedstocks such as soybeans or corn which have a limited harvest window, algae multiply every hour can be harvested every day.”
GreenFuel and APS have been conducting a field assessment program over the past 18 months, and have moved into the next phase of study with the construction of an Engineering Scale Unit that will be completed in first quarter of 2007. “This project holds great promise as we look for ways to meet the energy needs of the second fastest growing state in the nation while maintaining a successful economy, quality lifestyle and healthy environment,” said Ed Fox, APS’ Vice President of Communications, Environment and Safety.
About Arizona Public Service Company
APS, Arizona’s largest and longest-serving electricity utility, serves about 1 million customers in 11 of the state’s 15 counties. With headquarters in Phoenix, APS is the largest subsidiary of Pinnacle West Capital Corp. (NYSE: PNW)
About GreenFuel Technologies Corporation
With more than a dozen pending patents, GreenFuel Technologies Corporation is the leading developer of systems for recycling rich CO2 streams from power and/or manufacturing plant flue gases to produce biofuels such as biodiesel, ethanol or methane. The company, which was founded in 2001, is headquartered in Cambridge, Massachusetts.
Filed under: Arizona, Arizona Biotech, Arizona State University, ASU, ASU Downtown, Biotech, City of Phoenix, City of Phoenix News, Community and Economic Development, Downtown Development, Downtown Phoenix, Economic Development, Education, Health, Health Care, Maricopa County, Medical, News, Phoenix, Phoenix Arizona, State of Arizona, University of Arizona, US - AZ (Phoenix) | Tags: Back to School, Biomedical, Construction, Phoenix Biomedical Campus
Historic Phoenix Union High School Re-Opens as State-of-the-Art Biomedical Campus
The city of Phoenix in collaboration with the University of Arizona College of Medicine, the state of Arizona and Arizona State University opened the new Phoenix Biomedical Campus.
More here: Phoenix Biomedical Campus
Filed under: Arizona, Arizona Biotech, Biotech, Business, City of Tempe, City of Tempe News, State of Arizona, Tempe, US - AZ (Phoenix)
Local Biotech GenoSensor Signs Exclusive Deal with German Life-Science Company BioCat.
Tempe, Arizona, USA October 2, 2006
Tempe based GenoSensor Corporation officially launched its microRNA product line into the European market today by signing a distribution deal with German life science company BioCat GmbH. The move was strategic for both parties, giving GenoSensor penetration into the vast life science and pharmaceutical markets in the European Union, while allowing BioCat to have exclusive distribution rights to the unique product line. After watching GenoSensor grow during the past year, BioCat proposed the deal, realizing the international recognition GenoSensor’s products were receiving.
About GenoSensor
GenoSensor is a privately held biotechnology company aiming to improve lives by providing genomic research products and services worldwide for gene _expression profiling and genotyping, biomarker discovery, target validation, therapeutic assessment, and other bioscience applications. Major products include microRNA profiling packages, as well as custom dna-arrays for gene _expression and genotyping.
About BioCat
BioCat GmbH provides innovative tools and services for research in molecular and cell biology. Products and services are provided by BioCat´s partners in the USA, Korea, Taiwan, Russia, Finnland and Germany. BioCat is committed to a dedicated customer service by providing application oriented solutions. www.biocat.com.de